Frontiers
US$ 21.78
glp 1 forum National Minority Quality Launches “Health Not Hype” Campaign During Obesity Care Week to Warn Patients About Risks of Compounded GLP-1 Drugs GLP-1 was a hot topic
Description
Learn about the benefits and practical steps for transitioning patients from GLP-1 RAs to dual GLP-1/GIP receptor agonists, such as tirzepatide, to improve glycemic control in adults with type 2 diabetes.
The GLP-1 drugs market size is predicted to grow from USD 58.05 billion in 2026 to USD 132.79 billion by 2035, driven by a CAGR of 9.63%.
Designed for athletes, used by all.
Coverage of the drugs for weight loss would end on Oct
Requires medical evaluation and approval by a licensed provider
GLP-1 weight loss treatments can come with side effects
